Sangamo Therapeutics (SGMO) Receivables Refunds (2023 - 2025)
Historic Receivables Refunds for Sangamo Therapeutics (SGMO) over the last 3 years, with Q3 2025 value amounting to $4.6 million.
- Sangamo Therapeutics' Receivables Refunds changed N/A to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year change of. This contributed to the annual value of $4.1 million for FY2024, which is 2951.65% up from last year.
- Per Sangamo Therapeutics' latest filing, its Receivables Refunds stood at $4.6 million for Q3 2025.
- In the past 5 years, Sangamo Therapeutics' Receivables Refunds ranged from a high of $4.6 million in Q2 2025 and a low of $3.1 million during Q4 2023
- Moreover, its 3-year median value for Receivables Refunds was $4.2 million (2025), whereas its average is $4.1 million.
- Within the past 5 years, the most significant YoY rise in Sangamo Therapeutics' Receivables Refunds was 2951.65% (2024), while the steepest drop was 2951.65% (2024).
- Over the past 3 years, Sangamo Therapeutics' Receivables Refunds (Quarter) stood at $3.1 million in 2023, then increased by 29.52% to $4.1 million in 2024, then grew by 13.02% to $4.6 million in 2025.
- Its Receivables Refunds was $4.6 million in Q3 2025, compared to $4.6 million in Q2 2025 and $4.2 million in Q1 2025.